About this trial
The first aim is to identify biomarkers that could distinguish between two different grades of brain cancer.
The second aim is to determine if changes in the levels of the identified biomarkers relate to disease progression and patient outcome.
All patients with suspected newly diagnosed brain cancer (glioma) who are planned to have surgical treatment.
Patients will be asked to donate blood samples at various time points before and during their treatment and once every 3-6 months post-treatment for up to 5 years, depending on the path of their disease.
These blood samples will be taken at time of normal blood work; therefore participants will experience no additional discomfort or pain and no additional visits will be required.
Where’s this trial being run?Beaumont Hospital
Can I join this study / trial?
The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.
Why not Print this page and bring it with you. It will help your doctor and research team advise you.Print this page
For more detailed informationClick Here
|Name:||Serum Protein Markers for Glioma|
Are gliomas in adults associated with a unique identifying serum protein signature?
|Principal Investigator:||Dr Verena Murphy (Cancer Trials Ireland)|
Cancer Trials Ireland.
Global: Not Applicable
Ireland: July 2009
|Global Recruitment Target:||Not Applicable|
|Ireland Recruitment Target:||130|